Since its founding in 1886, the company has grown to become one of the world's largest and most broadly based healthcare companies, with approximately 132,000 employees across the globe working every day to help change the trajectory of health for humanity.

“We recognize the unfortunate impact that the Covid-19 pandemic has had on people, communities, businesses and the world. While Johnson & Johnson’s first quarter results were strong, reflecting the resiliency of our diversified business, that narrative has understandably taken a back seat to the more pressing concern of addressing Covid-19,”says Joseph Wolk  Executive Vice President, Chief Financial Officer. “We are not only confident in winning the fight against this public health crisis with efforts such as our collaboration to co-fund investment in vaccine development, but we also have confidence in the fundamentals of our entire business, which are remarkably strong for the long term.”

Source